Prospective Research

The bug is the drug

Company Details

Prospective Research, Inc is creating feed incorporated preventative disease management solutions for the aquaculture industry that completely removes the need for antibiotics and medicated feed. The company’s technology platform allows them to modulate bacterial behavior using microbial signaling molecules for the local delivery of therapeutics directly inside the gut of any farmed species. The company seeds trillions of bacterial pharmacies into the microbiome of fin-fish, shrimp, and shellfish, and can selectively turn on bacterial genes encoding bio-active therapeutics inside the animal for protection against bacterial, fungal, and parasitic pathogens.

Company People

Dakota Hamill

Dakota Hamill
CEO & Co-Founder

Jake Cotter

Jake Cotter
COO & Co-Founder

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.